Download Files:
IDO-IN-8
SKU
HY-18770C-10 mg
Category Reference compound
Tags 3-Dioxygenase (IDO), Cancer, Indoleamine 2, Metabolic Enzyme/Protease
$900 – $1,440
Products Details
Product Description
– IDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC50 of 1-10 μM.
Web ID
– HY-18770C
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C18H21FN2O2
References
– [1]Mautino, et al. Preparation of fused imidazole derivatives as IDO inhibitors. From PCT Int. Appl. (2012), 20121018.
CAS Number
– 1402837-77-7
Molecular Weight
– 316.37
Compound Purity
– 99.99
SMILES
– O[C@H](CC1)CC[C@]1([H])[C@@H](O)C[C@H]2N3C(C4=C2C(F)=CC=C4)=CN=C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– Ethanol : 100 mg/mL (ultrasonic)
Target
– Indoleamine 2,3-Dioxygenase (IDO)
Isoform
– IDO
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.